http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0269389-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0825
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097
filingDate 1987-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0269389-B1
titleOfInvention Peptides
abstract The new peptides of the Formulae (1) Glp-Lys-NH2 (2) Glp-Glu-Lys-NH2 (3) Arg-Lys-Glu-NH2 (4) Arg-Lys-Asp-NH2 (5) Arg-Lys-Glu-OH (6) Arg-Lys-Gln-OH (7) Leu-Val-Ala-OH (8) Arg-Orn-Asp-Val-NH2 (9) Arg-Orn-Asp-Val-OH (10) Lys-Glu-Lys-Lys-OH (11) Lys-Leu-Lys-Lys-OH (12) Lys-Asp-Leu-Lys-OH (13) Glu-Leu-Val-Ala-OH and (14) Leu-Pro-Ala-Gly-OH and acid addition salts thereof inhibit the proliferation of leukaemic cells and exhibit immunostimulant effect.
priorityDate 1986-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128540257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136044839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51381126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129244491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129642410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17766865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19995088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128509153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1712093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227650816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129610504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21879777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12270430

Total number of triples: 53.